Experience

OCT is a leading CRO operational in Russia, Central and Eastern Europe and the US. With the team of more than 180 professionals, OCT provides full range of high-quality services within Phase I to IV and BE studies organization and conduct.

With local expertise in countries of operations and best possible quality, we advance Sponsor’s product through development and approval on time and within client's budget. Our experienced teams deliver quality results for our clients' drug research and development needs which may vary from full clinical trial program to standalone CRO service like medical writing, consultancy, project management/monitoring, data management/statistics.

Since 2005 OCT has been involved in more than 250 full-service and functional service projects in a number of therapeutic areas.

Please take a look at breakdown of the OCT experience by year, therapeutic area and phases below:

Indication Phase Year
Hematology oncology II 2017
Hematology oncology II 2017
Hematology oncology II 2017
Breast Cancer n/a 2017
B-cell Lymphomа II 2016
B-Cell Lymphoma III 2016
Chronic Lymphoma III 2016
Breast Cancer I 2016
Solid Tumors I 2016
Breast Cancer III 2016
Hematology oncology BE study 2016
Kidney cancer BE study 2016
Breast Cancer III 2016
Lymphoma III 2015
Breast Cancer III 2015
Breast Cancer III 2015
Breast Cancer III 2015
Breast Cancer I 2015
Hepatocellular Carcinoma I 2015
AML III 2015
Chemotherapy induced neutropenia I 2015
Leucosis BE study 2015
Ph + CML I 2015
Colorectal Cancer III 2015
Solid tumors I 2014
Breast cancer I 2014
Metastatic Breast Cancer II 2014
Advanced melanoma I 2014
Solid Tumors I 2013
Ovarian Cancer I 2013
Non-small Cell Lung Cancer IV 2013
Non-small cell lung and Epithelial ovarian cancer I 2013
Metastatic Cancer I 2013
Breast Cancer IV 2013
Advanced melanoma I 2013
Multiple Myeloma III 2012
Breast Cancer II 2012
Advanced Melanoma I 2012
Acute Myeloid Leukemia II 2012
Hepatocellular Carcinoma n/a 2012
Solid Tumors I 2011
Solid Tumors I 2011
Multiple Myeloma III 2011
Locally advanced pancreatic cancer II 2011
Head and Neck Cancer III 2011
Colorectal Cancer III 2011
Breast Cancer II 2011
Bladder cancer II 2011
Solid Tumors II 2010
Metastatic Breast Cancer II 2010
Endometrial Carcinoma II 2010
Colorectal Cancer II 2010
Colorectal cancer III 2010
Breast Cancer II 2009
Breast Cancer III 2009
Solid Tumors I 2008
Prostate cancer III 2008
Prostate cancer II 2008
Ovarian Cancer III 2008
Bone metastases, pain II 2008
Prostate cancer II 2007
Oncology, pain II 2007
Hepatic metastases II 2007
Breast Cancer, neutropenia III 2007
Breast Cancer II 2007
Breast Cancer II 2007
Acute Myeloid Leukosis n/a 2007
T-cell Leukemia II 2005
Immunotherapy in Renal Cell Carcinoma III 2005
Indication Phase Year
Hypertension BE study 2016
Heart Failure III 2014
Thoracic Aortic Aneurysm I 2014
Essential Arterial Hypertension III 2014
Thoracic Aortic Aneurysm I 2013
LV insufficiency IV 2013
Essential Hypertension III 2013
Atherosclerosis II 2013
Thromboembolitic events IV 2012
LV insufficiency IV 2012
Dislipidemia I 2012
Deep Vein Thrombosis III 2012
Coronary Artery Disease III 2012
Atrial Fibrillation IV 2012
Stable angina IV 2011
Isolated Systolic Hypertension III 2011
Acute Myocardial Infarction IV 2007
Acute Heart Failure III 2006
Indication Phase Year
Seborrheic dermatitis III 2017
Ischemic Foot Ulcers III 2011
Acne II 2006
Indication Phase Year
Type I Diabetes Mellitus n/a 2017
 Acromegaly IV 2015
Diabetic Neuropathy III 2014
Type 2 Diabetes Mellitus III 2013
Type 2 Diabetes Mellitus IV 2013
Type 2 Diabetes Mellitus I 2011
Hypothyreosis IV 2009
Diabetes Mellitus II 2009
Diabetes Mellitus II 2008
Indication Phase Year
Ulcerative Colitis I 2017
Ulcerative proctitis III 2016
Hepatic cirrhosis IV 2015
Hepatic cirrhosis IV 2015
Ulcerative Proctitis II 2012
Biliary Colic III 2011
Liver disorder IV 2010
Intestinal colics IV 2010
Hepatic cirrhosis III 2009
Gastroenterology, eradication of H. pylory II 2009
Crohn's disease II 2008
Irritable Bowel Syndrome III 2007
Indication Phase Year
Sexual dysfunction II 2015
Sexual dysfunction II 2015
Healthy volunteers I 2014
Vaginitis IV 2013
Gynecology III 2011
Indication Phase Year
HBeAg Negative Chronic Hepatitis B virus infection II 2013
Indication Phase Year
Pain III 2017
Chronic cerebral ischemia n/a 2017
Pain BE study 2016
Stroke diagnostic test III 2016
Mild cognitive impairment III 2015
Vestibular Vertigo BE study 2015
Pregnancy Exposure IV 2013
Multiple Sclerosis III 2013
Aneurysmal Subarachnoid Hemorrhage I 2013
Multiple Sclerosis I 2011
Back Pain III 2011
Multiple Sclerosis IV 2010
Neurology, brain vessel aneurism rupture III 2008
Indication Phase Year
Chronic Kidney Disease III 2012
Indication Phase Year
Dry Eye syndrome III 2016
Blepharitis III 2015
Corneal Injury I 2014
Ocular Inflammation Following Cataract Surgery III 2012
Age-related macular degeneration I 2008
Indication Phase Year
Respiratory Tract Infection IV 2014
Acute Otitis IV 2014
Sore throat III 2013
Rhinnitis IV 2010
Indication Phase Year
Acute diarrhea III 2017
Parenteral nutrition III 2014
Recurrent Upper Respiratory Tract Infections (RURTI) III 2013
Acute bronchitis IV 2010
Infant Colic II 2010
Intestinal colics IV 2010
Bronchitis, pneumonia, AS IV 2009
Nutrition, pediatrics III 2006
Indication Phase Year
Sexual dysfunction II 2015
Sexual dysfunction II 2015
Schizophrenia II 2014
Schizophrenia III 2014
Schizophrenia II 2014
Schizophrenia II 2013
Anxiety Disorder II 2011
Alcohol Abuse II 2011
Indication Phase Year
Flu vaccine I 2017
Pneumonia III 2015
Acute Viral Respiratory infections II 2015
Chronic Obstructive Pulmonary Disease (COPD) II 2014
Respiratory diseases I 2014
Pre-clinical Pre-clinical 2014
Recurrent Upper Respiratory Tract Infections (RURTI) III 2013
Respiratory Tract Infection IV 2013
Community Aquired Pneumonia IV 2013
Community Aquired Pneumonia III 2013
Chronic Obstructive Pulmonary Disease IV 2013
Sore Throat III 2012
Asthma III 2011
Acute bronchitis IV 2010
Sore Throat II 2010
Bronchitis, pneumonia, AS IV 2009
Indication Phase Year
Osteoarthritis III 2017
Rheumatoid Arthritis III 2016
Rheumatoid Arthritis III 2016
Rheumatoid Arthritis III 2016
Rheumatoid Arthritis I 2016
Acute Gout I 2016
Rheumatoid arthritis III 2015
Rheumatoid arthritis III 2015
Rheumatoid arthritis III 2015
Rheumatology III 2013
Rheumatoid Arthritis I 2013
Rheumatoid Arthritis IV 2011
Gout III 2011
Rheumatoid Arthritis II 2009
Rheumatoid Arthritis II 2008
Indication Phase Year
HIV BE study 2017
Tuberculosis II 2017
Flu vaccine III 2017
Flu vaccine I 2017
Tuberculosis II 2016
HIV BE study 2016
HIV BE study 2016
HIV BE study 2016
HIV BE study 2016
Pneumonia III 2015
Acute Viral Respiratory infections II 2015
HIV Infection II 2015
HIV Infection II 2015
Hepatitis B III 2015
Tuberculosis I 2015
HIV Infection IV 2015
Tuberculosis III 2014
Complicated urinary tract infections III 2014
Respiratory Tract Infection IV 2014
Recurrent Upper Respiratory Tract Infections (RURTI) III 2013
Respiratory Tract Infection IV 2013
Multiple Drug Resistant Tuberculosis IV 2013
Hepatitis B I 2013
HBeAg Negative Chronic Hepatitis B virus infection II 2013
Chronic hepatitis B II 2012
Acute bronchitis IV 2010
Bronchitis, pneumonia, AS IV 2009
Indication Phase Year
Osteoarthrosis IV 2017
Pain BE study 2016
Pain III 2016
Analgesic I 2016
Back pain III 2016
Diarrhea IV 2013
Aplastic Anemia IV 2013
Pain III 2012
Parenteral nutrition III 2011
Intensive care III 2011
Mastocytosis II 2010
Indication Phase Year
Parenteral Feeding III 2017
Acute posthemorrhagic anemia I 2015
Parenteral feeding II 2015
Hemorrhoid I 2015
Infusion therapy III 2014
Thoracic Aortic Aneurysm I 2014
Thoracic Aortic Aneurysm I 2013
Prophylaxis of thromboembolic complication in knee II 2013
Parenteral Nutrition III 2013
Wound healing, device II 2011
Central catheter's maintanance III 2011
Surgery, colorectal anastomosis I 2010
Major orthopedic surgery (pain model) III 2010
Indication Phase Year
Astenospermia II 2017
Erectile dysfunction BE study 2016
Kidney cancer BE study 2016
Sexual Dysfunction I 2016
Astenospermia II 2015
Sexual dysfunction II 2015
Complicated urinary tract infections III 2014
Chronic Prostatitis IV 2013
Erectile Dysfunction III 2009
Indication Phase Year
Lower limb ischemia II 2017
Stroke diagnostic test III 2016
Hypertension BE study 2016
Deep vein thrombosis III 2015
Thoracic Aortic Aneurysm I 2014
Thoracic Aortic Aneurysm I 2013
Deep Vein Thrombosis III 2012
Indication Phase Year
Stroke diagnostic test III 2016
* — Some of the projects conducted by OCT refer to several therapeutic areas.